SCHEMBL6664657

SCHEMBL6664657

O=c1nc(C(F)(F)F)cc(C=Cc2ccc(-c3ccccc3F)o2)[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.50
▸ KMT2A Q03164 7/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ POLB P06746 3/20 0.50
▸ USP2 O75604 2/20 0.50
▸ HTT P42858 2/20 0.50
▸ RECQL P46063 1/20 0.50
▸ TLR9 Q9NR96 1/20 0.50
▸ MAPT P10636 3/20 0.45
▸ HPGD P15428 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ PSD A5PKW4 1/20 0.42
▸ CRHBP P24387 1/20 0.42
▸ CRHR2 Q13324 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ PIK3CG P48736 1/20 0.42
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6665658 0.85 KMT2A (0.47) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL6684366 0.84 KMT2A (0.46) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL6668285 0.82 MEN1 (0.52) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL6597815 0.80 KDM4E (0.74) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL6597811 0.80 KDM4E (0.74) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL6664624 0.80 PSD (0.52) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL6591626 0.80 KDM4E (0.55) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL6591623 0.80 KDM4E (0.55) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL6662372 0.79 MEN1 (0.49) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL13479595 0.79 MEN1 (0.53) MEN1KMT2AKDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004016271-A1 PYRIMIDONES AS ANTIVIRAL AGENTS AXXIMA PHARMACEUTICALS AG (DE) 2004-02-26 — — WO disclosed
Send feedback